• The Korean Journal of Physiology
• /
• 제4권2호
• /
• pp.1-4
• /
• 1970

인삼주정추출물이 흰쥐의 몸 무게 증가에 어떤 영향을 미치는 지를 알기 위하여 각각 32마리의 흰쥐$(35{\sim}40gm)$ 수컷과 암컷을 다시 인삼군과 식염수군으로 나누어 다음과 같이 실험을 하였다. 인삼군에서는 몸 무게 100mg에 대하여 인삼주정추출액(생리적 식염수 1ml속에 4mg의 인삼주정추출물이 포함된 용액)을 0.5ml의 비율로 매일 등뒤 피하에 54일 동안 주사하였으며, 식염수군에는 생리적 식염수를 몸 무게 100gm에 대하여 0.5ml의 비율로 인삼군과 동일한 방법으로 주사하였다. 주사가 시작된 날로부터 3일 간격으로 54일 동안 몸 무게를 비교적 정확한 저울로 달았다. 이를 측정치를 지표로 하여 인삼이 몸 무게 증가에 미치는 영향을 관찰한 바 다음과 같은 결과를 얻었다. 1) 인삼 투여 후 30일 까지는 성별에 관계 없이 인삼이 몸 무게 증가에 별로 영향을 미치지 않았다. 2) 인삼 투여 30일 이후 부터는 성별에 관계없이 인삼이 흰쥐의 몸 무게를 현저하게 증가시킨다. 3) 실험시작 30일 이후의 인삼군 수컷의 몸 무게는 인삼군 암컷의 그것 보다 현저하게 증가하였다. 위의 결과들로 미루어 인삼은 흰쥐의 몸 무게를 증가시키는데 촉진적 영향을 미친다고 사료된다.

• 한국식품영양과학회지
• /
• 제13권2호
• /
• pp.136-142
• /
• 1984

토용분(士龍粉)의 영양효과(營養效果)를 알아보고자 평군 체중 (male)72.3${\pm}$1.7g, (female)71.8${\pm}$1.4g인 흰쥐를 암수 구별하여 대조군(對照群), 2% 토용분(土龍粉)을 3일(日)마다 첨가급식군(添加給食群), 2% 토용분(土龍粉)을 매일첨가급식군(每日添加給食群)으로 나누어 6주간(週間) 사육하면서 사료섭취량, 체중증가(體重增加), 식이효율(食餌效率), 단백질효율(蛋白質效率), 장기중량(臟器重量) 등과 혈액중(血液中)의 hematocrit, hemoglobin, total protein, albumin, A/G ratio, glucose, total cholesterol 함량(含量)등의 변화를 관찰(觀察)하여 다음과 같은 결과(結果)를 얻었다. 1. 사료섭취량은 암쥐의 매일토용분(每日土龍粉) 첨가급식군(添加給食群)이 대조군(對照群)에 비해 높은(p<0.05) 경향을 보였다. 2. 체중증가량(體重培加量)은 숫쥐의 매일토용분(每日土龍粉) 첨가급식군(添加給貪群)이 대조군(對照群)에 비해 높았다(p<0.05). 3. 식이효율(食餌效率), 단백질효율(蛋白質效率)은 암수 모두 2% 토용분(土龍粉) 첨가급식(添加絡食)으로는 큰 영향을 미치지 않았다. 4. 숫쥐에서 매일토용분첨가급식군(每日土龍粉添加緖食群)의 심장(心臟)과 폐(肺)의 중량(重量)이 대조군(對照群)에 비해 높은(p<0.05) 경향을 보였으나 간(肝), 신장(腎臟), 비장(脚臟)은 대조군(對照群)과 비슷한 경향이었다. 5. Hematocrit 치(値)는 암쥐에서 실험군(實驗群)들이 대조군(對照群)에 비해 높은 (p<0.05) 경향을 보였고, 숫쥐에서는 대조군(對照群)과 비슷한 경향이었다. 6. 혈액중(血液中) hemoglobin과 혈청중(血淸中) total protein, albumin, A/G ratio, total cholesterol, glucose 등은 대조군(對照群)과 실험군(實驗群)들이 비슷한 함량을 보였다.

• Biomolecules & Therapeutics
• /
• 제5권1호
• /
• pp.12-22
• /
• 1997

Intravenous and oral acute toxicity tests in ICR mice and SD rats and percutaneous acute toxicity tests in SD rats and NZW rabbits were conducted to evaluate the toxicity of DA-5018 and DA-5018 cream, respectively Clinical signs observed in mice and rats after the administration of DA-5018 were similar regardless of administration route. The observed clinical signs were jumping, wild running, lacrimation, ataxia, reddening of extremities and ears, ventral or lateral recumbency, respiratory distress, cyanosis, convulsion and death. Pulmonary enlargement and hemorrhage were observed in the animals died immediately after the dosing of DA-5018. At terminal necropsy, pulmonary enlargement and hemorrhage, corneal opacity and focal scabbing and depilation around nose were seen. LD$_{50}$ Values of DA-5018 are 11.5 mg/kg (mice, male), 12.6 mg/kg (mice, female), 88.3 mg/kg (rat, male) and 73.2 mg/kg (rat, female) in oral toxicity tests and 11.0 mg/kg (mice, male), 18.7 mg/kg (mice, female), 0.12 mg/kg (rat, male) and 0.32 mg/kg (rat, female) in i.v. toxicity tests. In the percutaneous acute toxicity tests of DA-5018 cream, no deaths occured in all the tested groups during 14-day observation period. There were also no abnormalities in the general conditions, body weight changes and on necropsy findings in all groups. LD$_{50}$ values of 0.1 ~0.9% DA-5018 creams in male and female rats and rabbits are >2000 mg/kg./kg.

• 대한약침학회지
• /
• 제17권2호
• /
• pp.18-26
• /
• 2014

Objectives: This study was performed to check for reversibility in the changes induced by a 13-week, repeated, dose toxicity test of Sweet Bee Venom (SBV) in Sprague-Dawley (SD) rats. Methods: Fifteen male and 15 female SD rats were treated with 0.28 mg/kg of SBV (high-dosage group) and the same numbers of male and female SD rats were treated with 0.2 mL/kg of normal saline (control group) for 13 weeks. We selected five male and five female SD rats from the high-dosage group and the same numbers of male and female SD rats from the control group, and we observed these rats for four weeks. We conducted body-weight measurements, ophthalmic examinations, urinalyses and hematology, biochemistry, histology tests. Results: (1) Hyperemia and movement disorder were observed in the 13-week, repeated, dose toxicity test, but these symptoms were not observed during the recovery period. (2) The rats in the high-dose group showed no significant changes in weight compared to the control group. (3) No significant differences in the ophthalmic parameters, urine analyses, complete blood cell counts (CBCs), and biochemistry were observed among the recovery groups. (4) No changes in organ weights were observed during the recovery period. (5) Histological examination of the thigh muscle indicated cell infiltration, inflammation, degeneration, necrosis of muscle fiber, and fibrosis during the treatment period, but these changes were not observed during the recovery period. The fatty liver change that was observed during the toxicity test was not observed during the recovery period. No other organ abnormalities were observed. Conclusion: The changes that occurred during the 13-week, repeated, dose toxicity test are reversible, and SBV can be safely used as a treatment modality.

• 한국식품위생안전성학회지
• /
• 제11권4호
• /
• pp.243-259
• /
• 1996

This study was performed to investigate the induction of experimental atherosclerosis in rats and inhibitory effects of aloe vera on progression of atherosclerosis in rats. Adose range finding study of cholesterol and vitamin D2 for the induction of atherosclerosis and studies on the subchronic effect of aloe vera and on the chronic effect of aloe vera were carried out. A total of 3-week old 125 male rats of Sprague-Dawley were divided into 25 groups and fed with the diet containing cholesterol (0.1, 0.2, 0.3, 0.5, 1.0 and 2.0%) and vitamin D2 (500, 5000, 50000 and 500, 000 IU/100 g) for 4 weeks. 35 male rats were divided into 7 groups and fed with the diet containing aloe vera with 1.0% of cholesterol and 50, 000 IU/100 g of vitamin D2 for 4 weeks. 200 male rats were divided into 5 groups and fed with cholesterol and vitamin D2 for 6 and 12 months. Growth, clinical and pathological changes of rats in the three experiments were observed. The results were as follows: 1. In the dose-range finding study, feed intake, feed efficiency ratio and weight to body weight were increased in all of the feed groups containing 500, 000 IU/100 g of vitamin D2. Serum biochemical values of total cholesterol, high-density lipiprotein cholesterol (HDL-cholesterol), triglyceride, calcium, inorganic phosphorous and chloride of male rats in treated groups. The aorta and coronary artery of rats in all of the diet group containing 500, 000 IU/100 g of vitamin D2 showed typical atherosclerotic lesions. 2. Male rats fed with the diet containing aloe vera with 1.0% cholesterol and 50, 000 IU/100 g of vitamin D2 for 6 and 12 months did not show significant difference of diet intake and weight gain, and relative organ weight. The level of serum HDL-cholesterol and triglyceride recovered to the normal range by the aloe vera ingestation. 3. The aorta showed irregular appearence in the tunica intima with swelling, necrosis and calcification. The aorta of rat fed aloe vera diet showed no pathological lesions such as atherosclerosis of aorta. Aloe vera could have a helpful effect of vitamin D2 and cholesterol induced atherosclerosis in rats. Long-term supplementation of aloe vera may slow down the process of experimental atherosclerosis in rats have effects on the development of atherosclerosis.

• Biomolecules & Therapeutics
• /
• 제1권2호
• /
• pp.251-261
• /
• 1993

The subacute toxicity of combined antibiotics, SP-102 (Sulbactam.Piperacilline), was examined in S.D.rats. Four groups of rats were administered intraperitoneally with 0, 512, 1280 and 3200 mg/kg/day of SP-102 for 30 days. Hain clinical sign related to the compound was soft stool. The body weight gain was slightly decreased in male rats treated with 1280, 3200 mg/kg and in female rats treated with 1280 mg/kg of SP-102. Water consumption was significantly increased in rats administered with SP-102. There were no dose-related changes of urinalysis, biochemical examination and hematological findings in all the groups treated with SP-102. Gross necropsy and histopathology revealed no evidence of specific toxicity related to SP-102. Our data indicate that no-observed effect level of SP-102 is below 512 mg/kg in male and female rats. Maximum tolerated dose of SP-102 was estimated to be above 3200 ma/kg in this study.

• 한국임상수의학회지
• /
• 제17권1호
• /
• pp.285-288
• /
• 2000

Nine immature 30-day-old female rats were injected sc at 0800 hr with pregnant mare serum gonadotrophin(PMSG) to induce ovulation and mating. Fifty-six hours later the animals were placed with mature male rats overnight (one female and one male). Five of 9 immature female rats treated with PMSG were pregnant and allowed to maintain the pregnancy to term. Three of 5 pregnant rats were failed to maintain pregnancy to term. Two of 5 pregnant rats seemed to be developed normally and increased abdominal enlargement as pregnancy progresses, but did not occurred parturition on day of 43 or 48 of pregnancy, respectively. On day 44 or 49, pregnant rats were killed and examined uterus and ovaries. There was no fetus but approximately 50∼60ml. of mucopurulent fluids were accumulated in the uterine cavity and 40 or 42 corpora lutea persisted in the ovaries. Pyometra was developed after coitus in PMSG-treated immature female rat.

• Journal of Nutrition and Health
• /
• 제38권5호
• /
• pp.373-379
• /
• 2005

This study was performed to determine the effect of isoflavone on bone mineral density and bone mineral content in growing male rats. Twenty male, Sprague-Dawley rats were assigned to groups, that underwent 9 weeks of experi-ental treatment. Animals were assigned to one of two diet groups (casein group or casein supplemented with isoflavones). During 9 week of the study, food consumption was determined every other day through the measurement of total food given subtracting the food uneaten from original amount given. Rats in two experimental groups had similar initial body weights. At the end of experiment, however, the casein group had significantly greater body weights compared to casein supplemented with isoflavones group. It was also observed that the casein group had greater food intake comared to casein supplemented with isoflavones group. The difference in the final body weights of the groups was therefore due to difference in amount of food ingested, but could be due to the effect of isoflavones. Total BMD, spine BMD, and spine BMC per weight and femoral BMD per weight were significantly greater in casein supplemented with isolaones group than casein group. ALP and osteocalcin were significantly greater in the casein-fed group. Crosslink value was significantly lower in the casein supplemented with isoflavones group, All other variables were statistically similar between two groups. Overall, it can be concluded that casein supplemented with isoflavones beneficial for acquisition of bone mineral density and content on growing male rats.

• Toxicological Research
• /
• 제21권3호
• /
• pp.263-269
• /
• 2005

This study was performed to investigate repeated-dose toxicities of Clean natural, a new disinfectant, in Sprague-Dawley(SD) rats. In the 4-week repeated oral toxicity study, Clean Natural was orally administered once daily via gavage to male and female rats at dose levels of 0, 500, 1,000 and 2,000 mg/kg body weight for 4-weeks. There were no deaths and clinical signs during the dosing period. In both sexes, there were no statistically significant differences between the administered and control groups in urinalysis indicators and hematological parameters. In serum biochemistry, aspartate aminotransferase(AST) was significantly decreased and sodium content was increased in the 2,000 mg/kg male group, while chlorine was significantly decreased in the 2,000 mg/kg female group. Also, albumin, total cholesterol and total bilirubin were significantly increased in the 2,000 mg/kg male and female group. In histopathological examinations, centrilobular hepatocellular hypertrophy in the liver was observed in the 2,000 mg/kg male and female groups. And pigmentation in the spleen was observed in the 2,000 mg/kg male group. In conclusion, four-week repeated oral dose of Clean Natural to rats did not cause apparent toxicological change at the dose less than 2,000 mg/kg body weight. Thus it is suggested that no-observed adverse-effect level(NOAEL) for Clean Natural in rats was considered to be 1,000 mg/kg/day.

• Toxicological Research
• /
• 제20권2호
• /
• pp.143-151
• /
• 2004

This study was to investigate single and repeated-dose toxicities of CJ-11555, an anticirrhotic agent, in Sprague-Dawley (SO) rats. In single-dose oral toxicity study, the test article were administered once by gavage to males and females at dose levels of 0 and 2,000 mg/kg. No dead animals and abnormal necropsy findings were found in control and CJ-11555 treated group. Therefore, the approximate lethal dose of CJ-11555 was considered to be higher than 2,000 mg/kg in rats. In the 4-week repeated oral toxicity study, the test article was administered once daily by gavage to male and female rats at dose levels of 0, 10, 50 and 200 mg/kg/day for 4-weeks. In clinical signs, yellow-colored urine and yellow hair coat were observed in the 50 and 200 mg/kg male and female groups. In hematology, erythrocyte count and hemoglobin were significantly decreased in the 200mg/kg male and female groups. In serum biochemistry, total cholesterol was significantly increased and aspartate aminotransferase (AST) was significantly decreased in the 50 or 200 mg/kg male and female groups. In histopathological examinations, centrilobular hepatocellular hypertrophy in the liver, congestion and pigmentation in the spleen, hyaline droplets in the kidney were observed in the 50 and 200 mg/kg male and female groups. In toxicokinetic study, CJ-11555 was dose-dependent in systemic exposure and showed better absorption in female with minimum accumulation after multidosing. Based on these results, it was concluded that the 4-week repeated oral dose of CJ-11555 resulted in the suppression of AST activity and centrilobular hepatocellular hypertrophy in both sexes at a dose level of 50 or 200 mg/kg/day. The target organ was estimated to be liver, spleen and male's kidney. The no-observed-adverse-effect level (NOAEL) for CJ-11555 in rats following gavage for at least 4-week is 10 mg/kg/day.